There were a lot of responses to my pharma twittersphere analysis – thank you all for so enthousiastically contributing! Most of the discussion focused on the issues pharma twitter accounts …
Name:
Email:
Great news, we've signed you up. Sorry, we weren't able to sign you up. Please check your details, and try again.
MS patient meets German clinical trial
Becoming a "patient-like-me" in EU
